Miracle Mile Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.3M Buy
5,678
+75
+1% +$30.4K 0.04% 241
2025
Q1
$2.79M Buy
5,603
+93
+2% +$46.3K 0.06% 186
2024
Q4
$2.87M Sell
5,510
-405
-7% -$211K 0.06% 179
2024
Q3
$3.66M Buy
5,915
+155
+3% +$95.9K 0.08% 132
2024
Q2
$3.19M Buy
5,760
+320
+6% +$177K 0.08% 145
2024
Q1
$3.16M Buy
5,440
+121
+2% +$70.3K 0.08% 150
2023
Q4
$2.82M Sell
5,319
-1,150
-18% -$610K 0.08% 148
2023
Q3
$3.27M Buy
6,469
+12
+0.2% +$6.07K 0.1% 127
2023
Q2
$3.37M Sell
6,457
-236
-4% -$123K 0.1% 131
2023
Q1
$3.86M Sell
6,693
-461
-6% -$266K 0.12% 129
2022
Q4
$3.94M Buy
7,154
+2,937
+70% +$1.62M 0.14% 134
2022
Q3
$2.14M Buy
4,217
+132
+3% +$67K 0.1% 141
2022
Q2
$2.22M Sell
4,085
-633
-13% -$344K 0.1% 139
2022
Q1
$2.79M Sell
4,718
-5,208
-52% -$3.08M 0.12% 132
2021
Q4
$6.62M Buy
9,926
+305
+3% +$204K 0.26% 81
2021
Q3
$5.5M Buy
9,621
+171
+2% +$97.7K 0.26% 80
2021
Q2
$4.77M Buy
9,450
+52
+0.6% +$26.2K 0.25% 77
2021
Q1
$4.29M Buy
9,398
+5,854
+165% +$2.67M 0.24% 86
2020
Q4
$1.65M Buy
3,544
+524
+17% +$244K 0.1% 163
2020
Q3
$1.33M Buy
3,020
+1,890
+167% +$834K 0.09% 160
2020
Q2
$409K Sell
1,130
-110
-9% -$39.8K 0.03% 239
2020
Q1
$352K Buy
1,240
+163
+15% +$46.3K 0.04% 205
2019
Q4
$350K Buy
1,077
+33
+3% +$10.7K 0.02% 226
2019
Q3
$304K Buy
1,044
+309
+42% +$90K 0.02% 231
2019
Q2
$216K Hold
735
0.02% 244
2019
Q1
$201K Buy
+735
New +$201K 0.02% 251